Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride

Neurodegeneration is the main cause for permanent disability in multiple sclerosis. The effect of current immunomodulatory treatments on neurodegeneration is insufficient. Therefore, direct neuroprotection and myeloprotection remain an important therapeutic goal. Targeting acid-sensing ion channel 1...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Arun, T, Tomassini, V, Sbardella, E, De Ruiter, M, Matthews, L, Leite, M, Gelineau-Morel, R, Cavey, A, Vergo, S, Craner, M, Fugger, L, Rovira, A, Jenkinson, M, Palace, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Yazar: Arun, T, Tomassini, V, Sbardella, E, de Ruiter, M, Matthews, L, Leite, M, Gelineau-Morel, R, Cavey, A, Vergo, S, Craner, M, Fugger, L, Rovira, A, Jenkinson, M, Palace, J

Baskı/Yayın Bilgisi 2013

Journal article

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Yazar: Arun, T, Tomassini, V, Sbardella, E, de Ruiter, M, Matthews, L, Leite, M, Gelineau-Morel, R, Cavey, A, Vergo, S, Craner, M, Fugger, L, Rovira, A, Jenkinson, M, Palace, J

Benzer Materyaller